NCT00187941 MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression Status COMPLETED Phase EARLY_PHASE1
NCT00180895 Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL Status TERMINATED Phase PHASE2
NCT00178425 PK of MMF in Cadaveric vs Living Donor Liver Transplant Recipients Status COMPLETED Phase PHASE4
NCT00176059 Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients Status COMPLETED Phase EARLY_PHASE1
NCT00170131 MMF Influence on HCV Viral Evolution After Liver Transplantation Status COMPLETED Phase N/A
NCT00169195 Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma Status COMPLETED Phase PHASE2
NCT00169156 A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma Status COMPLETED Phase PHASE2
NCT00169000 Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers Status COMPLETED Phase PHASE1
NCT00168519 Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Status COMPLETED Phase NA
NCT00166296 Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients Status COMPLETED Phase PHASE2
NCT00166244 Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation Status COMPLETED Phase PHASE4
NCT00164190 Routine Angioplasty and Stenting After Fibrinolysis for Acute Myocardial Infarction Status COMPLETED Phase NA
NCT00160966 Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy Status COMPLETED Phase PHASE4
NCT00160407 Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE4
NCT00159432 Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00158522 Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213) Status COMPLETED Phase PHASE3
NCT00158496 Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211) Status COMPLETED Phase PHASE3